126 filings
D
AVTX
Avalo Therapeutics Inc
9 Apr 24
$199.98 mm in equity / options, sold $130.60 mm, 25 investors
4:58pm
424B5
AVTX
Avalo Therapeutics Inc
7 Aug 23
Prospectus supplement for primary offering
5:26pm
S-8
AVTX
Avalo Therapeutics Inc
4 May 23
Registration of securities for employees
5:10pm
424B5
AVTX
Avalo Therapeutics Inc
4 May 23
Prospectus supplement for primary offering
5:04pm
POS AM
AVTX
Avalo Therapeutics Inc
25 Apr 23
Prospectus update (post-effective amendment)
4:09pm
424B5
moihy120bkk 2f7wjvlb
3 Feb 23
Prospectus supplement for primary offering
4:02pm
424B5
g5971rx
2 Feb 23
Prospectus supplement for primary offering
4:03pm
S-8
mx0kru h2hjr6i
7 Nov 22
Registration of securities for employees
7:43am
424B5
mjmvz
15 Sep 21
Prospectus supplement for primary offering
4:41pm
424B5
qn4h7g exwfho
14 Sep 21
Prospectus supplement for primary offering
4:05pm
424B5
53qzbuomq3m4au0wu
2 Jul 21
Prospectus supplement for primary offering
4:09pm
S-8
7q5wzxv5tp9j9j9kic
13 May 21
Registration of securities for employees
4:14pm
S-8
13szj
13 May 21
Registration of securities for employees
4:11pm
S-8
tdjo6r2hfghxoi
13 May 21
Registration of securities for employees
4:07pm
424B5
6xq8h
8 Jan 21
Prospectus supplement for primary offering
5:02pm
424B5
ftobgn tqy
7 Jan 21
Prospectus supplement for primary offering
5:07pm
S-8
7ndmeinks66wjm85
6 Aug 20
Registration of securities for employees
4:27pm
424B5
a5ooff
9 Jun 20
Prospectus supplement for primary offering
5:22pm